Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model

IntroductionStreptococcus uberis (S. uberis) is a major pathogen that causes acute clinical mastitis and its recurrent episodes in dairy cows.MethodsIn this study, a peristaltic pump one-compartment open model was established to investigate the relationship between the pharmacokinetic and pharmacody...

Full description

Saved in:
Bibliographic Details
Main Authors: Chongyang Li, Junli Wang, Fanxi Guo, Fengyichi Zhang, Baochang Chen, Zihan Wang, Di Cao, Zugong Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1533892/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849316316958162944
author Chongyang Li
Junli Wang
Fanxi Guo
Fengyichi Zhang
Baochang Chen
Zihan Wang
Di Cao
Zugong Yu
author_facet Chongyang Li
Junli Wang
Fanxi Guo
Fengyichi Zhang
Baochang Chen
Zihan Wang
Di Cao
Zugong Yu
author_sort Chongyang Li
collection DOAJ
description IntroductionStreptococcus uberis (S. uberis) is a major pathogen that causes acute clinical mastitis and its recurrent episodes in dairy cows.MethodsIn this study, a peristaltic pump one-compartment open model was established to investigate the relationship between the pharmacokinetic and pharmacodynamic (PK/PD) indices of cefquinome (CFQ) against S. uberis. Bactericidal effects of single high-dosage versus multiple low-dosage administrations within the same drug dosage and best-fit dosage were assessed.ResultsStatic time-killing curves showed that the population of S. uberis was not changed when the drug concentration was below 1 × MIC. The maximum antibacterial effect was observed at 24 h, when the concentration exceeded 2 × MIC, showing a reduction by 5.73 log10 (CFU/mL), and the maximum kill rate was 0.22 h−1. S. uberis were cleared at 120 h when the concentration was ≥1 mg/L within single high-dosage groups, except for the 0.28 and 0.5 mg/L groups. The multiple-dose groups decreased below 2.22 log10 (CFU/mL) at 48 h and increased to 9 log10 (CFU/mL) at 120 h, but the group of 0.25 mg/L (4, q24) increased at 144 h. As the frequency of administration increased, the lag time increased following a population decline. The correlation coefficients between AUC0-72h/MBC, %T > MBC, and the antibacterial effects were 0.90 and 0.99%, respectively. %T > MBC was the best-fit PK/PD parameter of CFQ against S. uberis. The MIC of S1–S5 strains ranged from 0.0156–0.0625 μg/mL, and biofilm formation ability increased.DiscussionIn conclusion, CFQ showed good efficacy and time-dependence. This study provides a reference for optimizing CFQ administration in S. uberis.
format Article
id doaj-art-02efd5887a2b439ebf9cf643d2eab6f3
institution Kabale University
issn 1664-302X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-02efd5887a2b439ebf9cf643d2eab6f32025-08-20T03:51:49ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-07-011610.3389/fmicb.2025.15338921533892Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic modelChongyang LiJunli WangFanxi GuoFengyichi ZhangBaochang ChenZihan WangDi CaoZugong YuIntroductionStreptococcus uberis (S. uberis) is a major pathogen that causes acute clinical mastitis and its recurrent episodes in dairy cows.MethodsIn this study, a peristaltic pump one-compartment open model was established to investigate the relationship between the pharmacokinetic and pharmacodynamic (PK/PD) indices of cefquinome (CFQ) against S. uberis. Bactericidal effects of single high-dosage versus multiple low-dosage administrations within the same drug dosage and best-fit dosage were assessed.ResultsStatic time-killing curves showed that the population of S. uberis was not changed when the drug concentration was below 1 × MIC. The maximum antibacterial effect was observed at 24 h, when the concentration exceeded 2 × MIC, showing a reduction by 5.73 log10 (CFU/mL), and the maximum kill rate was 0.22 h−1. S. uberis were cleared at 120 h when the concentration was ≥1 mg/L within single high-dosage groups, except for the 0.28 and 0.5 mg/L groups. The multiple-dose groups decreased below 2.22 log10 (CFU/mL) at 48 h and increased to 9 log10 (CFU/mL) at 120 h, but the group of 0.25 mg/L (4, q24) increased at 144 h. As the frequency of administration increased, the lag time increased following a population decline. The correlation coefficients between AUC0-72h/MBC, %T > MBC, and the antibacterial effects were 0.90 and 0.99%, respectively. %T > MBC was the best-fit PK/PD parameter of CFQ against S. uberis. The MIC of S1–S5 strains ranged from 0.0156–0.0625 μg/mL, and biofilm formation ability increased.DiscussionIn conclusion, CFQ showed good efficacy and time-dependence. This study provides a reference for optimizing CFQ administration in S. uberis.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1533892/fullpharmacokineticpharmacodynamicsimulationdynamic modelsingle high dosagemultiple low-dosage
spellingShingle Chongyang Li
Junli Wang
Fanxi Guo
Fengyichi Zhang
Baochang Chen
Zihan Wang
Di Cao
Zugong Yu
Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
Frontiers in Microbiology
pharmacokinetic
pharmacodynamic
simulation
dynamic model
single high dosage
multiple low-dosage
title Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
title_full Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
title_fullStr Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
title_full_unstemmed Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
title_short Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
title_sort pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against streptococcus uberis in vitro dynamic model
topic pharmacokinetic
pharmacodynamic
simulation
dynamic model
single high dosage
multiple low-dosage
url https://www.frontiersin.org/articles/10.3389/fmicb.2025.1533892/full
work_keys_str_mv AT chongyangli pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT junliwang pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT fanxiguo pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT fengyichizhang pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT baochangchen pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT zihanwang pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT dicao pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel
AT zugongyu pharmacokineticandpharmacodynamicintegrationandresistanceanalysisofcefquinomeagainststreptococcusuberisinvitrodynamicmodel